Many Drug Companies Fail to Conduct Timely Postapproval Safety Checks Many Drug Companies Fail to Conduct Timely Postapproval Safety Checks

In the rush to approve new medicines, the U.S. Food and Drug Administration often requires drug companies to study possible side effects and alternative doses for medicines once they hit the broader market.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Internal Medicine News Source Type: news